Director, Employee Communications
CG Oncology
Summary
The Director, Employee Communications will build and lead CG Oncology's internal communications function as the company prepares for its transition from a late-stage clinical organization to a commercial one. Reporting to the Vice President of Communications and Patient Advocacy, this individual will be the company's first dedicated leader for employee communications, responsible for keeping a fast-growing, fully remote workforce informed, aligned and engaged around CG Oncology's strategy, milestones and culture.
Job description
About the role
The Director, Employee Communications will build and lead CG Oncology's internal communications function as the company prepares for its transition from a late-stage clinical organization to a commercial one. Reporting to the Vice President of Communications and Patient Advocacy, this individual will be the company's first dedicated leader for employee communications, responsible for keeping a fast-growing, fully remote workforce informed, aligned and engaged around CG Oncology's strategy, milestones and culture.
Internal Communications Strategy & Leadership
- Develop and lead CG Oncology's employee communications plan and execution, aligned with corporate priorities, the company narrative and the needs of a rapidly growing, fully remote workforce.
- Build the function's operating model, including channels, editorial calendar, governance, approval processes and measures of success.
- Serve as a trusted advisor on how and when to communicate with employees on strategy, performance and change.
- Ensure internal and external messages are consistent, timely and coordinated, with employees hearing important news first or at the same time as external audiences wherever appropriate.
Executive & Leadership Communications
- Plan and produce all-hands and town hall meetings, including agendas, talking points, presentations and follow-up.
- Equip people managers with toolkits, talking points and Q&A documents so they can cascade information and answer questions from their teams.
- Support executive visibility inside the company through regular, authentic communications that reinforce CG Oncology's Vision, Mission and Values.
Milestone, Launch & Change Communications
- Lead internal communications for regulatory, clinical, corporate and commercial milestones, including BLA submission, FDA decisions, data readouts and product launch.
- Develop news-day playbooks that coordinate employee communications with press releases, investor communications and external announcements.
- Plan and execute change communications for organizational growth, new functions, leadership changes and, where applicable, integration of acquired teams.
Channels, Content & Culture
- Own and evolve internal channels such as the intranet, email newsletters, collaboration platforms and virtual events, using data and emerging AI capabilities to improve reach and relevance.
- Create compelling content, including stories, features, videos and recognition programs, that highlights patient impact, scientific progress and team achievements.
- Partner with Human Resources on onboarding communications, culture and engagement initiatives, benefits and total rewards communications, and employee surveys.
- Serve as a 'communications business partner' to key functions at times of scale.
Compliance, Cross-Functional Collaboration & Analytics
- Ensure employee communications comply with applicable SEC regulations, Regulation FD disclosure requirements, insider trading policies and FDA guidance, and that material non-public information is handled appropriately.
- Partner closely with Human Resources, Legal, Regulatory, Medical Affairs, Commercial and Investor Relations to ensure accuracy, compliance and alignment.
- Measure the reach and effectiveness of employee communications through engagement data, surveys and feedback; prepare regular reports and recommendations for executive leadership.
- Manage agency partners, freelancers and vendors, including scoping, contracting and budget.
Requirements
- Bachelor's degree in Communications, Public Relations, Journalism, English or related field
- 10+ years of experience in internal, employee or corporate communications, including significant experience in biotechnology or pharmaceutical companies
- Experience within a publicly traded company and/or agency supporting biotech/pharma clients
- Direct experience building or scaling an internal communications function, ideally through a period of rapid growth
- Proven experience writing for and advising senior executives, including CEO communications
- Experience communicating with remote or distributed workforces
- Strong understanding of SEC regulations, disclosure requirements and handling of material non-public information
- Excellent written and verbal communication skills, with strong editorial judgment
- Demonstrated ability to simplify complex scientific and business information for diverse audiences
- Experience working closely with Human Resources on culture, engagement and change initiatives
- Experience working with external agency partners
- Experience with vendor management including contracting
- Must be authorized to work for any employer in the U.S.; unable to sponsor or take over sponsorship of an employment visa
Benefits
- Competitive Salaries
- Annual Performance/Merit Reviews
- Annual Performance Bonuses
- Equity
- Special Recognition
- Fully Remote Work Environment
- Unlimited Flexible Time Off
- 14 Holidays
- 401(k) Safe Harbor Match
- Medical, Dental & Vision
- HSA with Company Contribution
- FSA
- Company Paid LTD
- Life Insurance
- Voluntary Legal & Pet
Company overview
CG Oncology, Inc. (Nasdaq: CGON) is a late-stage clinical biopharmaceutical company headquartered in Irvine, California, focused exclusively on developing and commercializing innovative bladder-sparing therapeutics for patients afflicted with bladder cancer. Founded in 2010 and publicly traded since 2024, the company is dedicated to transforming the treatment landscape for urologic cancer patients through its pioneering oncolytic immunotherapy platform. CG Oncology's lead candidate, cretostimogene grenadenorepvec, is an intravesically delivered oncolytic immunotherapy agent currently in Phase 3 trials for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The company's innovative approach combines direct tumor cell lysis with immune system activation, offering a potential backbone therapeutic that could preserve bladder function while effectively treating cancer. With a specialized focus on immuno-oncology for bladder cancer, CG Oncology has established itself as a leader in this therapeutic area, advancing multiple clinical programs including combination studies with checkpoint inhibitors like KEYTRUDA® and OPDIVO®. The company's mission centers on enabling patients to live with dignity and improved quality of life through bladder-sparing treatment alternatives.